About Doc Generici
DOC Generici was founded in 1996 and is based in Milan, Italy. Operations focus on the generic pharmaceuticals sector, with specialization in ophthalmology. Treatments for macular degeneration, dry eye, glaucoma, and related eye conditions are developed and produced. The company serves the Italian market as a key player in these fields, emphasizing accessible healthcare solutions.
- Headquarter Milan, Italy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Doc Pharma
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Doc Generici
Unlock access to complete
Funding Insights of Doc Generici
Detailed funding history for Doc Generici
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Doc Generici
Doc Generici has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include CVC, ICG and Charterhouse Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are managed by Charterhouse Capital Partners.
|
Locked | Locked | Locked | |
|
Mezzanine financing and equity investments are provided by CVC.
|
Locked | Locked | Locked | |
|
ICG is recognized as a global alternative asset manager.
|
Locked | Locked | Locked |
Investor details for Doc Generici
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Doc Generici
Investment portfolio details for Doc Generici
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Doc Generici
Detailed financials for Doc Generici
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Doc Generici Comparisons
Peer comparison for Doc Generici
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Doc Generici
Detailed competitors of Doc Generici
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Doc Generici
Complete news archive for Doc Generici
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Doc Generici
Doc Generici was founded in 1996.
Doc Generici is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.
Gualtiero Pasquarelli is the current CEO of Doc Generici.
DOC Generici was founded in 1996 and is based in Milan, Italy. Operations focus on the generic pharmaceuticals sector, with specialization in ophthalmology. Treatments for macular degeneration, dry eye, glaucoma, and related eye conditions are developed and produced. The company serves the Italian market as a key player in these fields, emphasizing accessible healthcare solutions.
Doc Generici has 4 investors. Key investors include CVC, ICG, Charterhouse Capital Partners, and Merieux Equity Partners.